RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+8.8%
5Y CAGR+14.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+8.8%/yr
vs +24.0%/yr prior
5Y CAGR
+14.1%/yr
Recent deceleration
Acceleration
-15.2pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $112.44M | -17.4% |
| 2024 | $136.10M | +7.1% |
| 2023 | $127.06M | +45.5% |
| 2022 | $87.32M | +19.6% |
| 2021 | $73.02M | +25.3% |
| 2020 | $58.26M | +33.5% |
| 2019 | $43.63M | +18.1% |
| 2018 | $36.95M | +26.0% |
| 2017 | $29.33M | - |